1. Home
  2. DCGO vs CBUS Comparison

DCGO vs CBUS Comparison

Compare DCGO & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.70

Market Cap

67.0M

Sector

Health Care

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$2.24

Market Cap

69.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCGO
CBUS
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
67.0M
69.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DCGO
CBUS
Price
$0.70
$2.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$3.33
$20.00
AVG Volume (30 Days)
874.8K
378.5K
Earning Date
02-26-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$368,093,385.00
$3,794,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$106.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$1.09
52 Week High
$5.68
$3.40

Technical Indicators

Market Signals
Indicator
DCGO
CBUS
Relative Strength Index (RSI) 30.80 62.36
Support Level $0.74 $2.05
Resistance Level $0.80 $2.38
Average True Range (ATR) 0.06 0.23
MACD -0.01 0.05
Stochastic Oscillator 11.37 83.70

Price Performance

Historical Comparison
DCGO
CBUS

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: